10 Years On, How Has The America Invents Act Changed Medtech?

A patent attorney spoke to Medtech Insight about the pros and cons of 2011’s America Invents Act, including the inter partes review process and the first-to-file policy.

This month marks a decade since the transformative America Invents Act was signed into law, and its impact on patent-holders in the medtech sector has been significant – albeit in ways that weren’t expected in 2011, intellectual property attorney Robb Roby told Medtech Insight in a recent interview.

The AIA had a range of effects large and small. A crucial one has been the switch from the prior...